| Acronym |
Full Name |
Score |
Rating |
Judge me |
Search |
| IR |
immunoreactive |
205 |
5 |
good
bad
|
 |
| IR |
immunoreactivity |
149 |
9 |
good
bad
|
|
| IR |
insulin receptor |
134 |
6 |
good
bad
|
|
| IR |
ionizing radiation |
90 |
12 |
good
bad
|
|
| IR |
Insulin Resistance |
62 |
10 |
good
bad
|
|
| IR |
infrared |
61 |
5 |
good
bad
|
|
| IR |
inverted repeat |
32 |
19 |
good
bad
|
|
| IR |
immune response |
32 |
11 |
good
bad
|
|
| IR |
immune response |
32 |
11 |
good
bad
|
|
| IR |
Immediate Release |
23 |
-1 |
good
bad
|
|
| IR |
inversion recovery |
22 |
6 |
good
bad
|
|
| IR |
infrared spectroscopy |
17 |
11 |
good
bad
|
|
| IR |
incidence rate |
16 |
8 |
good
bad
|
|
| IR |
ischemia-reperfusion |
15 |
12 |
good
bad
|
|
| IR |
inhibition rate |
13 |
24 |
good
bad
|
|
| IR |
immediate-release |
12 |
12 |
good
bad
|
|
| IR |
(NPY)-immunoreactive |
8 |
8 |
good
bad
|
|
| IR |
ionising radiation |
7 |
6 |
good
bad
|
|
| IR |
GABA-immunoreactive |
6 |
9 |
good
bad
|
|
| IR |
insulin receptors |
6 |
9 |
good
bad
|
|
| IR |
CGRP-immunoreactive |
6 |
8 |
good
bad
|
|
| IR |
(CGRP)-immunoreactive |
6 |
7 |
good
bad
|
|
| IR |
(TH)-immunoreactive |
6 |
6 |
good
bad
|
|
| IR |
incomplete repair |
6 |
5 |
good
bad
|
|
| IR |
ischemia and reperfusion |
6 |
1 |
good
bad
|
|
| IR |
immunoreactivities |
5 |
13 |
good
bad
|
|
| IR |
SP-immunoreactive |
5 |
12 |
good
bad
|
|
| IR |
HOMA |
5 |
0 |
good
bad
|
|
| IR |
near-infrared |
4 |
13 |
good
bad
|
|
| IR |
ChAT-immunoreactive |
4 |
13 |
good
bad
|
|
| IR |
inferior rectus |
4 |
12 |
good
bad
|
|
| IR |
NPY-immunoreactive |
4 |
11 |
good
bad
|
|
| IR |
interventional radiology |
4 |
9 |
good
bad
|
|
| IR |
information retrieval |
4 |
9 |
good
bad
|
|
| IR |
Fos-immunoreactive |
4 |
8 |
good
bad
|
|
| IR |
interquartile range |
4 |
7 |
good
bad
|
|
| IR |
(5-HT)-immunoreactive |
4 |
4 |
good
bad
|
|
| IR |
Inversion-Recovery |
4 |
2 |
good
bad
|
|
| IR |
inverted repeats |
4 |
1 |
good
bad
|
|
| IR |
(SP)-immunoreactive |
4 |
1 |
good
bad
|
|
| IR |
serotonin-immunoreactive |
3 |
15 |
good
bad
|
|
| IR |
ubiquitin-immunoreactive |
3 |
13 |
good
bad
|
|
| IR |
inactive renin |
3 |
11 |
good
bad
|
|
| IR |
inwardly rectifying |
3 |
11 |
good
bad
|
|
| IR |
incidence rates |
3 |
10 |
good
bad
|
|
| IR |
ileal reservoir |
3 |
10 |
good
bad
|
|
| IR |
implantation rate |
3 |
10 |
good
bad
|
|
| IR |
intestinal polypeptide (VIP)-immunoreactive |
3 |
10 |
good
bad
|
|
| IR |
(NOS)-immunoreactive |
3 |
9 |
good
bad
|
|
| IR |
intergenic region |
3 |
9 |
good
bad
|
|
| IR |
infra-red |
3 |
9 |
good
bad
|
|
| IR |
5-immunoreactive |
3 |
8 |
good
bad
|
|
| IR |
instant release |
3 |
8 |
good
bad
|
|
| IR |
interdigitating reticulum |
3 |
6 |
good
bad
|
|
| IR |
input resistance |
2 |
18 |
good
bad
|
|
| IR |
intraruminal |
2 |
15 |
good
bad
|
|
| IR |
LHRH-immunoreactive |
2 |
14 |
good
bad
|
|
| IR |
NOS-immunoreactive |
2 |
12 |
good
bad
|
|
| IR |
VIP-immunoreactive |
2 |
12 |
good
bad
|
|
| IR |
NOS-immunoreactivity |
2 |
11 |
good
bad
|
|
| IR |
VT-immunoreactive |
2 |
11 |
good
bad
|
|
| IR |
intestinal peptide (VIP)-immunoreactive |
2 |
10 |
good
bad
|
|
| IR |
inhibitory ratio |
2 |
10 |
good
bad
|
|
| IR |
Induction of Fos-like immunoreactivity |
2 |
10 |
good
bad
|
|
| IR |
SUR1/K |
2 |
10 |
good
bad
|
|
| IR |
increased the number of Fos-immunoreactive |
2 |
10 |
good
bad
|
|
| IR |
in levels of immunoreactive |
2 |
9 |
good
bad
|
|
| IR |
GFAP-immunoreactivity |
2 |
9 |
good
bad
|
|
| IR |
Irradiation |
2 |
9 |
good
bad
|
|
| IR |
c-Fos-immunoreactive |
2 |
9 |
good
bad
|
|
| IR |
innervation ratio |
2 |
8 |
good
bad
|
|
| IR |
PKC-beta-immunoreactive |
2 |
8 |
good
bad
|
|
| IR |
(AVP)-immunoreactive |
2 |
8 |
good
bad
|
|
| IR |
inward rectifier K(+) (K |
2 |
8 |
good
bad
|
|
| IR |
CaBP-immunoreactive |
2 |
8 |
good
bad
|
|
| IR |
infrared spectrophotometry |
2 |
7 |
good
bad
|
|
| IR |
insulin release |
2 |
7 |
good
bad
|
|
| IR |
GnRH-immunoreactive |
2 |
7 |
good
bad
|
|
| IR |
in ischemia-reperfusion |
2 |
7 |
good
bad
|
|
| IR |
inducible resistance |
2 |
7 |
good
bad
|
|
| IR |
Infrared spectra |
2 |
6 |
good
bad
|
|
| IR |
T-immunoreactivity |
2 |
6 |
good
bad
|
|
| IR |
internal rotation |
2 |
6 |
good
bad
|
|
| IR |
PACAP-immunoreactive |
2 |
5 |
good
bad
|
|
| IR |
AM-immunoreactive |
2 |
5 |
good
bad
|
|
| IR |
imidazoline receptors |
2 |
5 |
good
bad
|
|
| IR |
PNMT-immunoreactive |
2 |
5 |
good
bad
|
|
| IR |
IGF-I receptors (IGF-IR) and insulin receptors |
2 |
5 |
good
bad
|
|
| IR |
(CRH)-immunoreactive |
2 |
4 |
good
bad
|
|
| IR |
infection rates |
2 |
4 |
good
bad
|
|
| IR |
(CRF)-immunoreactive |
2 |
4 |
good
bad
|
|
| IR |
in immunoreactive |
2 |
2 |
good
bad
|
|
| IR |
alpha-immunoreactivity |
1 |
20 |
good
bad
|
|
| IR |
imidazol(in)e |
1 |
19 |
good
bad
|
|
| IR |
implant withdrawal |
1 |
19 |
good
bad
|
|
| IR |
infectious rhinitis |
1 |
18 |
good
bad
|
|
| IR |
immuno-reactivities |
1 |
18 |
good
bad
|
|
| IR |
VMAT2-immunoreactivity |
1 |
18 |
good
bad
|
|
| IR |
(TH)-only'-immunoreactive |
1 |
18 |
good
bad
|
|
| IR |
II (A II) immunoreactivity |
1 |
17 |
good
bad
|
|
| IR |
IFABP-immunoreactive |
1 |
17 |
good
bad
|
|
| IR |
Immunohistochemical analyses revealed that c-Met-immunoreactivity |
1 |
17 |
good
bad
|
|
| IR |
increase ratio |
1 |
17 |
good
bad
|
|
| IR |
increase in plasma immunoreactive |
1 |
16 |
good
bad
|
|
| IR |
induce an increase of inward-rectifying |
1 |
16 |
good
bad
|
|
| IR |
in groups II |
1 |
16 |
good
bad
|
|
| IR |
IGF-I receptor (IGF-IR) and insulin receptor |
1 |
16 |
good
bad
|
|
| IR |
OA-immunoreactive |
1 |
16 |
good
bad
|
|
| IR |
FGF-immunoreactivity |
1 |
16 |
good
bad
|
|
| IR |
ileo-urethrostomy with a reservoir |
1 |
15 |
good
bad
|
|
| IR |
(ERalpha)-immunoreactivity |
1 |
15 |
good
bad
|
|
| IR |
incomplete resection alone |
1 |
15 |
good
bad
|
|
| IR |
investigates immunoreactive |
1 |
15 |
good
bad
|
|
| IR |
intracellular distribution of immunoreactive |
1 |
15 |
good
bad
|
|
| IR |
FMRFamide-immunoreactive |
1 |
15 |
good
bad
|
|
| IR |
imidazoline receptor |
1 |
14 |
good
bad
|
|
| IR |
items that varied on category |
1 |
14 |
good
bad
|
|
| IR |
(5-HT)-immunoreactivity |
1 |
14 |
good
bad
|
|
| IR |
increase of CGRP-immunoreactivity |
1 |
14 |
good
bad
|
|
| IR |
increase in intracellular NO in NIH-3T3 |
1 |
14 |
good
bad
|
|
| IR |
regulated by immune response |
1 |
14 |
good
bad
|
|
| IR |
in the infrared |
1 |
14 |
good
bad
|
|
| IR |
in the HOMA-insulin resistant |
1 |
14 |
good
bad
|
|
| IR |
infarcted region |
1 |
14 |
good
bad
|
|
| IR |
Inflammatory resorption |
1 |
14 |
good
bad
|
|
| IR |
incident review |
1 |
14 |
good
bad
|
|
| IR |
NGFr-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
CR-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
(CB)-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
5-HT-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
(bFGF)-immunoreactivity |
1 |
13 |
good
bad
|
|
| IR |
dopamine-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
inwardly rectifying K(+) channels (K |
1 |
13 |
good
bad
|
|
| IR |
II insulin-requiring |
1 |
13 |
good
bad
|
|
| IR |
(NK1R)-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
C-ACTH-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
inactive renin levels |
1 |
13 |
good
bad
|
|
| IR |
inspiratory resistor |
1 |
13 |
good
bad
|
|
| IR |
(hcrt-1)-like-immunoreactivity |
1 |
13 |
good
bad
|
|
| IR |
interrater agreement |
1 |
13 |
good
bad
|
|
| IR |
SSD-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
inwardly rectifying K+ current |
1 |
13 |
good
bad
|
|
| IR |
inhibitory rates |
1 |
13 |
good
bad
|
|
| IR |
MCH-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
Na+/K+-ATPase-immunoreactive |
1 |
13 |
good
bad
|
|
| IR |
mGnRH-immunoreactive |
1 |
12 |
good
bad
|
|
| IR |
investigated by means of immunocytochemistry |
1 |
12 |
good
bad
|
|
| IR |
mutant K |
1 |
12 |
good
bad
|
|
| IR |
VRL-1-immunoreactive |
1 |
12 |
good
bad
|
|
| IR |
SK3-immunoreactivity |
1 |
12 |
good
bad
|
|
| IR |
Initial drug resistance |
1 |
12 |
good
bad
|
|
| IR |
interchromatin region |
1 |
12 |
good
bad
|
|
| IR |
identified significant amounts of immunoreactive |
1 |
12 |
good
bad
|
|
| IR |
glycine-immunoreactive |
1 |
12 |
good
bad
|
|
| IR |
GluR2-immunoreactivity |
1 |
12 |
good
bad
|
|
| IR |
TRH-immunoreactivity |
1 |
12 |
good
bad
|
|
| IR |
GFAP-immunoreactive |
1 |
12 |
good
bad
|
|
| IR |
infrared absorption |
1 |
12 |
good
bad
|
|
| IR |
NK-1r-immunoreactive |
1 |
12 |
good
bad
|
|
| IR |
intestinal ischemia-reperfusion |
1 |
12 |
good
bad
|
|
| IR |
insulin stimulation of NIH-3T3 |
1 |
12 |
good
bad
|
|
| IR |
inversion-time (TI) inversion-recovery |
1 |
12 |
good
bad
|
|
| IR |
identical ischemia-reperfusion |
1 |
12 |
good
bad
|
|
| IR |
S100-immunoreactive |
1 |
11 |
good
bad
|
|
| IR |
ischaemia reperfusion untreated |
1 |
11 |
good
bad
|
|
| IR |
intermediate-range |
1 |
11 |
good
bad
|
|
| IR |
initially reactive |
1 |
11 |
good
bad
|
|
| IR |
inhibitory response |
1 |
11 |
good
bad
|
|
| IR |
Ir-coated catheter |
1 |
11 |
good
bad
|
|
| IR |
intermediate or resistant |
1 |
11 |
good
bad
|
|
| IR |
infrared marker |
1 |
11 |
good
bad
|
|
| IR |
inactivation response |
1 |
11 |
good
bad
|
|
| IR |
index of reactivity |
1 |
11 |
good
bad
|
|
| IR |
cathepsin-immunoreactive |
1 |
11 |
good
bad
|
|
| IR |
in immunoreactivity |
1 |
11 |
good
bad
|
|
| IR |
4-polyisoprene |
1 |
11 |
good
bad
|
|
| IR |
GAD-immunoreactivity |
1 |
11 |
good
bad
|
|
| IR |
(SN)-immunoreactivity |
1 |
11 |
good
bad
|
|
| IR |
in the appearance of ChAT-immunoreactivity |
1 |
11 |
good
bad
|
|
| IR |
in response to gamma-irradiation |
1 |
11 |
good
bad
|
|
| IR |
Anti-mGluR2/3-immunoreactive |
1 |
11 |
good
bad
|
|
| IR |
in met-enkephalin-immunoreactivity |
1 |
11 |
good
bad
|
|
| IR |
(TH)-only-immunoreactive |
1 |
11 |
good
bad
|
|
| IR |
Index of Recession |
1 |
10 |
good
bad
|
|
| IR |
(GAL)-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
infrared rays |
1 |
10 |
good
bad
|
|
| IR |
ET-1-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
nNOS-immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
(GnRH)-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
internal repeat |
1 |
10 |
good
bad
|
|
| IR |
Fos-immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
isotope renography |
1 |
10 |
good
bad
|
|
| IR |
GAT-1-immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
Immunocytochemistry showed intensely stained NOS-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
ODC-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
PRV-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
Kit-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
inhibition ratio |
1 |
10 |
good
bad
|
|
| IR |
Immuno-reactive |
1 |
10 |
good
bad
|
|
| IR |
intra-rectal |
1 |
10 |
good
bad
|
|
| IR |
(PNMT)-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
irrigation |
1 |
10 |
good
bad
|
|
| IR |
initiator region |
1 |
10 |
good
bad
|
|
| IR |
(GAD)-immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
min-ischemia-reperfusion |
1 |
10 |
good
bad
|
|
| IR |
incidence ratio |
1 |
10 |
good
bad
|
|
| IR |
[NGFr(p75)]-immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
inwardly rectifying K(+) currents (I |
1 |
10 |
good
bad
|
|
| IR |
D28k-immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
CB-immunoreactive |
1 |
10 |
good
bad
|
|
| IR |
NGFr-immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
inferior rectus muscle |
1 |
10 |
good
bad
|
|
| IR |
in rat K |
1 |
10 |
good
bad
|
|
| IR |
in NIH-3T3 |
1 |
10 |
good
bad
|
|
| IR |
immediate release capsule |
1 |
10 |
good
bad
|
|
| IR |
increases in c-Fos immunoreactivity |
1 |
10 |
good
bad
|
|
| IR |
(PR)-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
insulin-stimulated processes in 32D |
1 |
9 |
good
bad
|
|
| IR |
Ischemic preconditioning protects against ischemia-reperfusion |
1 |
9 |
good
bad
|
|
| IR |
NIH-3T3 |
1 |
9 |
good
bad
|
|
| IR |
inverted repeated sequence |
1 |
9 |
good
bad
|
|
| IR |
ignored repetition |
1 |
9 |
good
bad
|
|
| IR |
inflammatory response |
1 |
9 |
good
bad
|
|
| IR |
(PV)-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
cell surface receptor |
1 |
9 |
good
bad
|
|
| IR |
initiation region |
1 |
9 |
good
bad
|
|
| IR |
identification in TECs/TNCs of immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
immediate resuscitation |
1 |
9 |
good
bad
|
|
| IR |
I(h) and I(K |
1 |
9 |
good
bad
|
|
| IR |
interaction between gamma-aminobutyric acid (GABA)-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
leu-enkephalin-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
mIgG-like-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
I receptor (IGF-IR) on ionizing radiation |
1 |
9 |
good
bad
|
|
| IR |
immunohistochemistry revealed close appositions between GABA-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
Individual GFAP immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
inertial range |
1 |
9 |
good
bad
|
|
| IR |
increases in QUIN immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
increases in plasma beta-endorphin |
1 |
9 |
good
bad
|
|
| IR |
TrkA-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
in position 23 of K |
1 |
9 |
good
bad
|
|
| IR |
investigated the maturation of TK-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
in response to ionizing radiation |
1 |
9 |
good
bad
|
|
| IR |
VR1-immunoreactivity |
1 |
9 |
good
bad
|
|
| IR |
Y1-R-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
CGRP-immunoreactivity |
1 |
9 |
good
bad
|
|
| IR |
inactive trypsin-activatable renin |
1 |
9 |
good
bad
|
|
| IR |
iridium |
1 |
9 |
good
bad
|
|
| IR |
Induced Reactivation |
1 |
9 |
good
bad
|
|
| IR |
ischaemia and 90 min reperfusion |
1 |
9 |
good
bad
|
|
| IR |
ischemia and 4 hours of reperfusion |
1 |
9 |
good
bad
|
|
| IR |
gamma-radiation |
1 |
9 |
good
bad
|
|
| IR |
irritant reaction |
1 |
9 |
good
bad
|
|
| IR |
impregnation ratio |
1 |
9 |
good
bad
|
|
| IR |
increases Beta-endorphin |
1 |
9 |
good
bad
|
|
| IR |
bFGF-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
receptor-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
calretinin-immunoreactive |
1 |
9 |
good
bad
|
|
| IR |
interstitial radiation |
1 |
9 |
good
bad
|
|
| IR |
Spectroscopic |
1 |
9 |
good
bad
|
|
| IR |
in GR immunoreactivity |
1 |
9 |
good
bad
|
|
| IR |
Hsp70-immunoreactivity |
1 |
8 |
good
bad
|
|
| IR |
integration region |
1 |
8 |
good
bad
|
|
| IR |
internal |
1 |
8 |
good
bad
|
|
| IR |
intensity ratio |
1 |
8 |
good
bad
|
|
| IR |
irrigated rice |
1 |
8 |
good
bad
|
|
| IR |
investigated using mid-infrared spectroscopy |
1 |
8 |
good
bad
|
|
| IR |
L-DOPA-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
double-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
investigate the presence of immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
intrarenal |
1 |
8 |
good
bad
|
|
| IR |
ghrelin-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
Indirect Radiological |
1 |
8 |
good
bad
|
|
| IR |
immunoreactive renin |
1 |
8 |
good
bad
|
|
| IR |
(PACAP)-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
(SOM)-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
(DA)-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
secretoneurin-immunoreactivity |
1 |
8 |
good
bad
|
|
| IR |
immune response genes |
1 |
8 |
good
bad
|
|
| IR |
induces tau-immunoreactivity |
1 |
8 |
good
bad
|
|
| IR |
Inhibition rates |
1 |
8 |
good
bad
|
|
| IR |
infrared analysis |
1 |
8 |
good
bad
|
|
| IR |
innervation of histamine-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
protein)-immunoreactivity |
1 |
8 |
good
bad
|
|
| IR |
parvalbumin-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
insulin resistant |
1 |
8 |
good
bad
|
|
| IR |
inadequate aspiration rate |
1 |
8 |
good
bad
|
|
| IR |
incomplete-repair |
1 |
8 |
good
bad
|
|
| IR |
significantly associated with the |
1 |
8 |
good
bad
|
|
| IR |
insulin levels and HOMA |
1 |
8 |
good
bad
|
|
| IR |
somatostatin-immunoreactive |
1 |
8 |
good
bad
|
|
| IR |
ischaemia reperfusion |
1 |
7 |
good
bad
|
|
| IR |
inventory ratio |
1 |
7 |
good
bad
|
|
| IR |
induced alterations in mAChR-immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
FMRFamide-like-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
Fe-restricted |
1 |
7 |
good
bad
|
|
| IR |
increased radio-resistence at higher doses |
1 |
7 |
good
bad
|
|
| IR |
(p75NTR)-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
TRH-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
in which a constant mu |
1 |
7 |
good
bad
|
|
| IR |
X-irradiation |
1 |
7 |
good
bad
|
|
| IR |
CR-immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
ipsilateral rotations |
1 |
7 |
good
bad
|
|
| IR |
inwardly rectifying K(+) currents (IK |
1 |
7 |
good
bad
|
|
| IR |
(ACTH)-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
inward rectifier (IK |
1 |
7 |
good
bad
|
|
| IR |
irregular regeneration of hepatocytes |
1 |
7 |
good
bad
|
|
| IR |
increase in immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
vasopressin-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
(GAD)-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
ED1-immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
trk-immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
CGA-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
(NT)-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
immunostained PKC-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
immune-regulating drugs |
1 |
7 |
good
bad
|
|
| IR |
NPFF-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
initial virological response |
1 |
7 |
good
bad
|
|
| IR |
intermediate risk |
1 |
7 |
good
bad
|
|
| IR |
intermediate |
1 |
7 |
good
bad
|
|
| IR |
identified by immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
idiopathic radioculopolyneuropathies |
1 |
7 |
good
bad
|
|
| IR |
immediate hypersensitivity responses |
1 |
7 |
good
bad
|
|
| IR |
IL-1beta-immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
II (ANG II)-like immunoreactivities |
1 |
7 |
good
bad
|
|
| IR |
4-immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
interobserver reproducibility |
1 |
7 |
good
bad
|
|
| IR |
intestinal peptide (VIP)-like immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
intestinal polypeptide (VIP) immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
ischemia reperfusion group |
1 |
7 |
good
bad
|
|
| IR |
c-Met-immunoreactivity |
1 |
7 |
good
bad
|
|
| IR |
intestinal pathology in intestinal ischemia-reperfusion |
1 |
7 |
good
bad
|
|
| IR |
infrared absorption spectrometry |
1 |
7 |
good
bad
|
|
| IR |
infra red |
1 |
7 |
good
bad
|
|
| IR |
ischemia/reperfusion |
1 |
7 |
good
bad
|
|
| IR |
interstitial radiotherapy |
1 |
7 |
good
bad
|
|
| IR |
infrared spectrophotometer |
1 |
7 |
good
bad
|
|
| IR |
beta-endorphin-immunoreactive |
1 |
7 |
good
bad
|
|
| IR |
acetyltransferase-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
CCK-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
NC-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
iridium(III) bis-terpyridine complex |
1 |
6 |
good
bad
|
|
| IR |
NPY-immunoreactivity |
1 |
6 |
good
bad
|
|
| IR |
alpha)-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
nNOS-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
(GR)-immunoreactivity |
1 |
6 |
good
bad
|
|
| IR |
iron reserves |
1 |
6 |
good
bad
|
|
| IR |
intestinal vascular endothelium after ischemia/reperfusion |
1 |
6 |
good
bad
|
|
| IR |
Intestinal Polypeptide)-like immunoreactivity |
1 |
6 |
good
bad
|
|
| IR |
interval running |
1 |
6 |
good
bad
|
|
| IR |
interstitial ratio |
1 |
6 |
good
bad
|
|
| IR |
interrupter technique |
1 |
6 |
good
bad
|
|
| IR |
immunoreaction product |
1 |
6 |
good
bad
|
|
| IR |
identified by synapsin-1 immunoreactivity |
1 |
6 |
good
bad
|
|
| IR |
intermediate region |
1 |
6 |
good
bad
|
|
| IR |
indicated that the SL-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
in insulin-resistant |
1 |
6 |
good
bad
|
|
| IR |
infection rate |
1 |
6 |
good
bad
|
|
| IR |
interposition |
1 |
6 |
good
bad
|
|
| IR |
intestinal resection |
1 |
6 |
good
bad
|
|
| IR |
increased the pituitary content of Beta-endorphin |
1 |
6 |
good
bad
|
|
| IR |
internal repeats |
1 |
6 |
good
bad
|
|
| IR |
increase in GFAP-immunoreactivity |
1 |
6 |
good
bad
|
|
| IR |
infrared reflection |
1 |
6 |
good
bad
|
|
| IR |
immobility responses |
1 |
6 |
good
bad
|
|
| IR |
investigated with infrared |
1 |
6 |
good
bad
|
|
| IR |
increase in PSA-NCAM-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
immunoreactivity in the sexually dimorphic CGRP-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
innervated by CARTp-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
Dopamine-beta-hydroxylase-immunoreactive |
1 |
6 |
good
bad
|
|
| IR |
Met-Enk-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
infrasonic recorder |
1 |
5 |
good
bad
|
|
| IR |
immunocytochemistry NGF-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
initiation |
1 |
5 |
good
bad
|
|
| IR |
in contact with NPY-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
(NPF)-immunoreactivity |
1 |
5 |
good
bad
|
|
| IR |
in Chinese hamster ovary/insulin receptor |
1 |
5 |
good
bad
|
|
| IR |
infectious rhinotracheitis |
1 |
5 |
good
bad
|
|
| IR |
NK3r-immunoreactivity |
1 |
5 |
good
bad
|
|
| IR |
implications of p63 immunoreactivity |
1 |
5 |
good
bad
|
|
| IR |
SOMmRNA-immunoreactivities |
1 |
5 |
good
bad
|
|
| IR |
increase in the density of GAD-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
isolectin B4- (IB4-) immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
intensity |
1 |
5 |
good
bad
|
|
| IR |
in the distribution of PV-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
ischemia reperfusion |
1 |
5 |
good
bad
|
|
| IR |
intestinal peptide)-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
incremental running |
1 |
5 |
good
bad
|
|
| IR |
iron removed |
1 |
5 |
good
bad
|
|
| IR |
synenkephalin-immunoreactivity |
1 |
5 |
good
bad
|
|
| IR |
isometric relaxation |
1 |
5 |
good
bad
|
|
| IR |
(NF)-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
Inwardly rectifying K(+) currents (K |
1 |
5 |
good
bad
|
|
| IR |
I + II immunoreactivity |
1 |
5 |
good
bad
|
|
| IR |
(AADC)-immunoreactive |
1 |
5 |
good
bad
|
|
| IR |
Immunohistochemical analysis revealed PACAP-immunoreactivity |
1 |
4 |
good
bad
|
|
| IR |
p75-immunoreactivity |
1 |
4 |
good
bad
|
|
| IR |
infrared radiation |
1 |
4 |
good
bad
|
|
| IR |
increased immunoreactivity |
1 |
4 |
good
bad
|
|
| IR |
in calcitonin gene-related peptide (CGRP)-immunoreactive |
1 |
4 |
good
bad
|
|
| IR |
indicated that GABA-immunoreactive |
1 |
4 |
good
bad
|
|
| IR |
SMI32-immunoreactive |
1 |
4 |
good
bad
|
|
| IR |
synaptophysin-immunoreactivity |
1 |
4 |
good
bad
|
|
| IR |
SN-immunoreactive |
1 |
4 |
good
bad
|
|
| IR |
including ROM and isokinetic internal rotation |
1 |
4 |
good
bad
|
|
| IR |
investigate the release of immunoreactive |
1 |
4 |
good
bad
|
|
| IR |
irregular regeneration |
1 |
4 |
good
bad
|
|
| IR |
isocentric rotation |
1 |
4 |
good
bad
|
|
| IR |
ischemic region |
1 |
4 |
good
bad
|
|
| IR |
galanin-immunoreactive |
1 |
4 |
good
bad
|
|
| IR |
Is detected by infrared |
1 |
4 |
good
bad
|
|
| IR |
immobility reflex |
1 |
4 |
good
bad
|
|
| IR |
initial increase of CGRP-immunoreactivity |
1 |
4 |
good
bad
|
|
| IR |
(S1)-immunoreactivity |
1 |
4 |
good
bad
|
|
| IR |
inverted-repeat |
1 |
4 |
good
bad
|
|
| IR |
isonymy |
1 |
3 |
good
bad
|
|
| IR |
isotope ratio |
1 |
3 |
good
bad
|
|
| IR |
Bcl-2-immunoreactivity |
1 |
3 |
good
bad
|
|
| IR |
TH-immunoreactive |
1 |
3 |
good
bad
|
|
| IR |
insulin-regulatable |
1 |
3 |
good
bad
|
|
| IR |
intense NCS-1-immunoreactive |
1 |
3 |
good
bad
|
|
| IR |
inwardly rectifying potassium current |
1 |
3 |
good
bad
|
|
| IR |
I (GCH)-immunoreactive |
1 |
3 |
good
bad
|
|
| IR |
injury following intestinal ischemia-reperfusion |
1 |
3 |
good
bad
|
|
| IR |
immunoactive |
1 |
3 |
good
bad
|
|
| IR |
insulin resistance HOMA |
1 |
3 |
good
bad
|
|
| IR |
sGnRH-immunoreactive |
1 |
3 |
good
bad
|
|
| IR |
(NKA)-immunoreactivity |
1 |
2 |
good
bad
|
|
| IR |
insulin-resistant |
1 |
2 |
good
bad
|
|
| IR |
insulin resistance index |
1 |
2 |
good
bad
|
|
| IR |
incomplete relaxation |
1 |
2 |
good
bad
|
|
| IR |
Index |
1 |
2 |
good
bad
|
|
| IR |
intermediate responders |
1 |
2 |
good
bad
|
|
| IR |
II immunoreactivity |
1 |
2 |
good
bad
|
|
| IR |
interpersonal relations |
1 |
2 |
good
bad
|
|
| IR |
isovolumic relaxation |
1 |
2 |
good
bad
|
|
| IR |
increase in immunoreactive |
1 |
2 |
good
bad
|
|
| IR |
(CGRP)-immunoreactivity |
1 |
1 |
good
bad
|
|
| IR |
inward rectification |
1 |
1 |
good
bad
|
|
| IR |
(VT)-immunoreactive |
1 |
1 |
good
bad
|
|
| IR |
incidence of multiple pregnancies |
1 |
1 |
good
bad
|
|
| IR |
ET-immunoreactivity |
1 |
1 |
good
bad
|
|
| IR |
oxytocin-immunoreactive |
1 |
1 |
good
bad
|
|
| IR |
innervation by MIP-immunoreactive |
1 |
1 |
good
bad
|
|
| IR |
increase in MOR immunoreactivity |
1 |
0 |
good
bad
|
|
| IR |
Visinin-immunoreactive |
1 |
0 |
good
bad
|
|
| IR |
inward rectifier K(+) channels K |
1 |
0 |
good
bad
|
|
| IR |
CRH-immunoreactivity |
1 |
-1 |
good
bad
|
|
| IR |
in EAAT1-immunoreactivity |
1 |
-1 |
good
bad
|
|